Goldman Sachs Group Inc Absci Corp Transaction History

Goldman Sachs Group Inc

  • $780 Billion
  • Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Absci Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 286,298 shares of ABSI stock, worth $818,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares
286,298
Previous 666,066 57.02%
Holding current value
$818,812
Previous $1.71 Million 49.15%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$2.34 - $3.63 $888,657 - $1.38 Million
-379,768 Reduced 57.02%
286,298 $870,000
Q2 2025

Aug 14, 2025
BUY
$2.24 - $3.22 $786,705 - $1.13 Million
351,208 Added 111.54%
666,066 $1.71 Million
Q1 2025

May 09, 2025
BUY
$2.51 - $5.82 $117,907 - $273,394
46,975 Added 17.54%
314,858 $790,000
Q4 2024

Feb 11, 2025
SELL
$2.55 - $4.38 $24,176 - $41,526
-9,481 Reduced 3.42%
267,883 $701,000
Q3 2024

Nov 14, 2024
SELL
$2.97 - $4.49 $1.09 Million - $1.65 Million
-368,225 Reduced 57.04%
277,364 $1.06 Million
Q2 2024

Aug 13, 2024
SELL
$2.92 - $6.58 $163,660 - $368,795
-56,048 Reduced 7.99%
645,589 $1.99 Million
Q1 2024

May 15, 2024
BUY
$3.41 - $5.74 $2.29 Million - $3.85 Million
670,327 Added 2140.94%
701,637 $3.99 Million
Q4 2023

Feb 13, 2024
BUY
$1.15 - $4.79 $328 - $1,369
286 Added 0.92%
31,310 $131,000
Q3 2023

May 14, 2024
SELL
$1.28 - $2.41 $366 - $689
-286 Reduced 0.91%
31,024 $40,000
Q3 2023

Nov 14, 2023
SELL
$1.28 - $2.41 $79,589 - $149,851
-62,179 Reduced 66.71%
31,024 $40,000
Q2 2023

May 14, 2024
BUY
$1.17 - $2.03 $8,629 - $14,973
7,376 Added 8.59%
93,203 $141,000
Q2 2023

Aug 14, 2023
BUY
$1.17 - $2.03 $8,629 - $14,973
7,376 Added 8.59%
93,203 $141,000
Q1 2023

May 14, 2024
BUY
$1.58 - $3.41 $4,419 - $9,537
2,797 Added 3.37%
85,827 $150,000
Q1 2023

May 11, 2023
BUY
$1.58 - $3.41 $4,419 - $9,537
2,797 Added 3.37%
85,827 $150,000
Q4 2022

May 14, 2024
BUY
$2.0 - $3.58 $2,218 - $3,970
1,109 Added 1.35%
83,030 $174,000
Q4 2022

Feb 13, 2023
BUY
$2.0 - $3.58 $2,218 - $3,970
1,109 Added 1.35%
83,030 $174,000
Q3 2022

May 14, 2024
SELL
$2.95 - $4.83 $16,254 - $26,613
-5,510 Reduced 6.3%
81,921 $256,000
Q3 2022

Nov 10, 2022
SELL
$2.95 - $4.83 $16,254 - $26,613
-5,510 Reduced 6.3%
81,921 $256,000
Q2 2022

May 14, 2024
BUY
$3.13 - $8.83 $175,658 - $495,548
56,121 Added 179.24%
87,431 $291,000
Q2 2022

Aug 15, 2022
SELL
$3.13 - $8.83 $10,623 - $29,969
-3,394 Reduced 3.74%
87,431 $291,000
Q1 2022

May 16, 2022
BUY
$5.87 - $9.46 $251,012 - $404,528
42,762 Added 88.97%
90,825 $765,000
Q4 2021

Feb 14, 2022
BUY
$7.88 - $18.03 $378,736 - $866,575
48,063 New
48,063 $394,000

Others Institutions Holding ABSI

# of Institutions
154
Shares Held
70.2M
Call Options Held
701K
Put Options Held
541K
View Full List

About Absci Corp

ABSI Quotes by TradingView
  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $266M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email